| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.824 | 0.003 | 0.885 | 5 Hydroxytryptamine release stimulant | 0.885 0.002 CID_3007 | CID_3007 | |
| 0.514 | 0.004 | 0.754 | 5 Hydroxytryptamine uptake stimulant | 0.754 0.001 CID_3007 | CID_3007 | |
| 0.536 | 0.03 | 0.536 | Antiobesity | 0.387 0.071 CID_3007 | ||
| 0.49 | 0.017 | 0.49 | Vasodilator, coronary | 0.387 0.04 CID_3007 | ||
| 0.471 | 0.014 | 0.682 | Psychostimulant | 0.682 0.004 CID_3007 | CID_3007 | |
| 0.377 | 0.006 | 0.377 | Bronchodilator | 0.107 0.056 CID_3007 | ||
| 0.356 | 0.015 | 0.653 | Tyrosine 3 hydroxylase inhibitor | 0.653 0.003 CID_3007 | CID_3007 | |
| 0.36 | 0.036 | 0.36 | Cardiotonic | |||
| 0.352 | 0.033 | 0.393 | Insulysin inhibitor | 0.393 0.023 CID_3007 | CID_3007 | |
| 0.325 | 0.019 | 0.325 | Gastrin inhibitor | 0.31 0.027 CID_3007 | ||
| 0.347 | 0.053 | 0.408 | Spasmolytic | 0.408 0.038 CID_3007 | CID_3007 | |
| 0.302 | 0.019 | 0.302 | Thiol protease inhibitor | 0.247 0.027 CID_3007 | ||
| 0.284 | 0.015 | 0.284 | Antiadrenergic | |||
| 0.277 | 0.015 | 0.277 | Adrenaline antagonist | |||
| 0.333 | 0.081 | 0.342 | Vasodilator, peripheral | 0.342 0.077 CID_3007 | CID_3007 | |
| 0.253 | 0.008 | 0.253 | Calcium antagonist | 0.119 0.036 CID_3007 | ||
| 0.319 | 0.08 | 0.35 | Cholesterol antagonist | 0.35 0.064 CID_3007 | CID_3007 | |
| 0.283 | 0.054 | 0.283 | Vasodilator | |||
| 0.302 | 0.078 | 0.337 | Immunostimulant | 0.337 0.068 CID_3007 | CID_3007 | |
| 0.229 | 0.016 | 0.297 | Cathepsin H inhibitor | 0.297 0.01 CID_3007 | CID_3007 | |
| 0.273 | 0.062 | 0.561 | Superoxide dismutase inhibitor | 0.561 0.009 CID_3007 | CID_3007 | |
| 0.258 | 0.049 | 0.283 | Neuropeptide Y2 antagonist | 0.283 0.028 CID_3007 | CID_3007 | |
| 0.274 | 0.068 | 0.274 | Ca(v)3.3 blocker | 0.209 0.172 CID_3007 | ||
| 0.333 | 0.13 | 0.614 | 5 Hydroxytryptamine release inhibitor | 0.614 0.009 CID_3007 | CID_3007 | |
| 0.254 | 0.061 | 0.302 | Calpain inhibitor | 0.302 0.029 CID_3007 | CID_3007 | |
| 0.207 | 0.016 | 0.211 | Falcipain 3 inhibitor | 0.211 0.015 CID_3007 | CID_3007 | |
| 0.302 | 0.113 | 0.369 | Calpain 2 inhibitor | 0.369 0.077 CID_3007 | CID_3007 | |
| 0.234 | 0.048 | 0.431 | Growth hormone agonist | 0.431 0.012 CID_3007 | CID_3007 | |
| 0.191 | 0.009 | 0.191 | Inducible nitric-oxide synthase inhibitor | 0.174 0.012 CID_3007 | ||
| 0.28 | 0.098 | 0.28 | Sodium/bile acid cotransporter inhibitor | |||
| 0.191 | 0.01 | 0.208 | Prolactin inhibitor | 0.208 0.008 CID_3007 | CID_3007 | |
| 0.21 | 0.03 | 0.21 | Anesthetic local | 0.204 0.031 CID_3007 | ||
| 0.2 | 0.021 | 0.302 | Aminopeptidase B inhibitor | 0.302 0.008 CID_3007 | CID_3007 | |
| 0.189 | 0.011 | 0.229 | Nitric-oxide synthase inhibitor | 0.229 0.006 CID_3007 | CID_3007 | |
| 0.205 | 0.032 | 0.26 | Neurotensin receptor agonist | 0.26 0.019 CID_3007 | CID_3007 | |
| 0.289 | 0.118 | 0.289 | Toll-Like receptor agonist | |||
| 0.288 | 0.118 | 0.288 | Toll-Like receptor 7 agonist | |||
| 0.2 | 0.034 | 0.211 | Nav1.2 sodium channel blocker | 0.211 0.031 CID_3007 | CID_3007 | |
| 0.19 | 0.029 | 0.19 | Proteasome inhibitor | 0.186 0.03 CID_3007 | ||
| 0.201 | 0.04 | 0.201 | MAO inhibitor | 0.19 0.044 CID_3007 | ||
| 0.163 | 0.01 | 0.259 | Aminopeptidase I inhibitor | 0.259 0.004 CID_3007 | CID_3007 | |
| 0.206 | 0.054 | 0.282 | 5 Hydroxytryptamine 3E antagonist | 0.282 0.007 CID_3007 | CID_3007 | |
| 0.152 | 0.005 | 0.152 | Sigma 1 receptor antagonist | 0.026 0.019 CID_3007 | ||
| 0.16 | 0.014 | 0.16 | Interleukin 1 beta converting enzyme inhibitor | 0.115 0.039 CID_3007 | ||
| 0.176 | 0.031 | 0.176 | Nav1.6 sodium channel blocker | 0.166 0.038 CID_3007 | ||
| 0.182 | 0.038 | 0.182 | Calcium channel blocker | |||
| 0.156 | 0.013 | 0.156 | Adrenaline agonist | 0.148 0.015 CID_3007 | ||
| 0.174 | 0.031 | 0.21 | Adenylate cyclase stimulant | 0.21 0.01 CID_3007 | CID_3007 | |
| 0.182 | 0.04 | 0.375 | Alpha-N-acetylglucosaminidase inhibitor | 0.375 0.01 CID_3007 | CID_3007 | |
| 0.19 | 0.051 | 0.242 | Phospholipase C inhibitor | 0.242 0.027 CID_3007 | CID_3007 | |
| 0.249 | 0.119 | 0.399 | Interleukin 2 agonist | 0.399 0.028 CID_3007 | CID_3007 | |
| 0.169 | 0.04 | 0.176 | Neuropeptide Y1 antagonist | 0.176 0.033 CID_3007 | CID_3007 | |
| 0.141 | 0.015 | 0.141 | Cathepsin L inhibitor | 0.078 0.026 CID_3007 | ||
| 0.248 | 0.129 | 0.366 | Transcription factor NF kappa B inhibitor | 0.366 0.072 CID_3007 | CID_3007 | |
| 0.126 | 0.009 | 0.126 | Beta adrenoreceptor antagonist | 0.076 0.03 CID_3007 | ||
| 0.261 | 0.145 | 0.419 | GABA C receptor rho-3 antagonist | 0.419 0.053 CID_3007 | CID_3007 | |
| 0.219 | 0.103 | 0.415 | Interleukin agonist | 0.415 0.017 CID_3007 | CID_3007 | |
| 0.118 | 0.006 | 0.118 | Cathepsin L2 inhibitor | 0.065 0.015 CID_3007 | ||
| 0.138 | 0.026 | 0.138 | Acetylcholine release stimulant | 0.129 0.035 CID_3007 | ||
| 0.287 | 0.175 | 0.287 | Cyclophilin D inhibitor | |||
| 0.254 | 0.143 | 0.315 | Calcium channel activator | 0.315 0.077 CID_3007 | CID_3007 | |
| 0.118 | 0.01 | 0.118 | Beta 3 adrenoreceptor antagonist | 0.08 0.023 CID_3007 | ||
| 0.116 | 0.008 | 0.116 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 CID_3007 | ||
| 0.111 | 0.004 | 0.111 | Dipeptidyl peptidase I inhibitor | 0.097 0.004 CID_3007 | ||
| 0.201 | 0.097 | 0.247 | Peptidyltransferase inhibitor | 0.247 0.053 CID_3007 | CID_3007 | |
| 0.189 | 0.085 | 0.253 | Insulin sensitizer | 0.253 0.033 CID_3007 | CID_3007 | |
| 0.132 | 0.029 | 0.144 | Factor V inhibitor | 0.144 0.021 CID_3007 | CID_3007 | |
| 0.143 | 0.042 | 0.143 | Calcium channel N-type blocker | 0.127 0.055 CID_3007 | ||
| 0.297 | 0.197 | 0.413 | Caspase 9 stimulant | 0.413 0.104 CID_3007 | CID_3007 | |
| 0.249 | 0.149 | 0.323 | Immunosuppressant | 0.323 0.101 CID_3007 | CID_3007 | |
| 0.108 | 0.012 | 0.108 | Vanilloid 4 agonist | 0.092 0.024 CID_3007 | ||
| 0.135 | 0.04 | 0.135 | Nav1.1 sodium channel blocker | 0.093 0.076 CID_3007 | ||
| 0.143 | 0.053 | 0.143 | Nav1.3 sodium channel blocker | 0.126 0.067 CID_3007 | ||
| 0.142 | 0.053 | 0.178 | Sphingosine 1-phosphate receptor 2 antagonist | 0.178 0.016 CID_3007 | CID_3007 | |
| 0.106 | 0.018 | 0.106 | Cannabinoid CB1 receptor agonist | |||
| 0.136 | 0.048 | 0.176 | Sphingosine 1-phosphate receptor 4 antagonist | 0.176 0.016 CID_3007 | CID_3007 | |
| 0.097 | 0.009 | 0.1 | Dipeptidyl peptidase inhibitor | 0.1 0.009 CID_3007 | CID_3007 | |
| 0.09 | 0.005 | 0.097 | Histamine H2 receptor agonist | 0.097 0.004 CID_3007 | CID_3007 | |
| 0.229 | 0.144 | 0.336 | Antithrombotic | 0.336 0.07 CID_3007 | CID_3007 | |
| 0.154 | 0.071 | 0.205 | Acetylcholine M1 receptor antagonist | 0.205 0.04 CID_3007 | CID_3007 | |
| 0.099 | 0.016 | 0.142 | Protease 3C (Human rhinovirus) inhibitor | 0.142 0.007 CID_3007 | CID_3007 | |
| 0.129 | 0.047 | 0.129 | Calcium channel (voltage-sensitive) blocker | |||
| 0.129 | 0.046 | 0.129 | MAO B inhibitor | 0.093 0.064 CID_3007 | ||
| 0.116 | 0.034 | 0.138 | Glutamate (mGluR7) agonist | 0.138 0.017 CID_3007 | CID_3007 | |
| 0.114 | 0.033 | 0.135 | Aminoacyl-tRNA synthetase inhibitor | 0.135 0.024 CID_3007 | CID_3007 | |
| 0.097 | 0.017 | 0.097 | Cathepsin B inhibitor | 0.068 0.03 CID_3007 | ||
| 0.089 | 0.009 | 0.089 | Beta 2 adrenoreceptor antagonist | 0.063 0.021 CID_3007 | ||
| 0.098 | 0.019 | 0.118 | Secretase beta inhibitor | 0.118 0.011 CID_3007 | CID_3007 | |
| 0.124 | 0.045 | 0.158 | Protease inhibitor | 0.158 0.026 CID_3007 | CID_3007 | |
| 0.133 | 0.056 | 0.14 | Acetylcholine muscarinic antagonist | 0.14 0.05 CID_3007 | CID_3007 | |
| 0.187 | 0.112 | 0.522 | Aldehyde oxidase inhibitor | 0.522 0.03 CID_3007 | CID_3007 | |
| 0.112 | 0.037 | 0.112 | Potassium channel activator | |||
| 0.082 | 0.008 | 0.082 | Beta 2 adrenoreceptor agonist | 0.079 0.009 CID_3007 | ||
| 0.098 | 0.026 | 0.098 | Calcium channel L-type blocker | |||
| 0.119 | 0.05 | 0.315 | GABA C receptor agonist | 0.315 0.008 CID_3007 | CID_3007 | |
| 0.087 | 0.019 | 0.087 | Sigma receptor antagonist | 0.047 0.036 CID_3007 | ||
| 0.292 | 0.224 | 0.424 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.424 0.081 CID_3007 | CID_3007 | |
| 0.096 | 0.029 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.02 CID_3007 | CID_3007 | |
| 0.071 | 0.004 | 0.085 | Histamine H1 receptor agonist | 0.085 0.003 CID_3007 | CID_3007 | |
| 0.098 | 0.032 | 0.597 | 5 Hydroxytryptamine 1F antagonist | 0.597 0.004 CID_3007 | CID_3007 | |
| 0.113 | 0.047 | 0.145 | Sphingomyelinase inhibitor | 0.145 0.027 CID_3007 | CID_3007 | |
| 0.069 | 0.004 | 0.069 | Cathepsin F inhibitor | 0.048 0.015 CID_3007 | ||
| 0.154 | 0.09 | 0.166 | Antipruritic | 0.166 0.077 CID_3007 | CID_3007 | |
| 0.104 | 0.04 | 0.14 | Ornithine decarboxylase inhibitor | 0.14 0.014 CID_3007 | CID_3007 | |
| 0.099 | 0.035 | 0.18 | Somatostatin 1 agonist | 0.18 0.009 CID_3007 | CID_3007 | |
| 0.116 | 0.056 | 0.199 | GABA C receptor antagonist | 0.199 0.013 CID_3007 | CID_3007 | |
| 0.075 | 0.015 | 0.075 | Myc inhibitor | |||
| 0.114 | 0.055 | 0.191 | MAO A inhibitor | 0.191 0.031 CID_3007 | CID_3007 | |
| 0.123 | 0.065 | 0.173 | Adenylate cyclase inhibitor | 0.173 0.033 CID_3007 | CID_3007 | |
| 0.071 | 0.013 | 0.071 | Cathepsin L1 inhibitor | 0.054 0.018 CID_3007 | ||
| 0.177 | 0.121 | 0.177 | ErbB-1 antagonist | |||
| 0.081 | 0.025 | 0.081 | Acetylcholine M3 receptor antagonist | |||
| 0.092 | 0.037 | 0.176 | Cathepsin G inhibitor | 0.176 0.018 CID_3007 | CID_3007 | |
| 0.137 | 0.085 | 0.186 | Hemostatic | 0.186 0.039 CID_3007 | CID_3007 | |
| 0.11 | 0.058 | 0.23 | DOPA decarboxylase inhibitor | 0.23 0.004 CID_3007 | CID_3007 | |
| 0.062 | 0.012 | 0.062 | Neurokinin 2 agonist | 0.058 0.014 CID_3007 | ||
| 0.07 | 0.019 | 0.088 | Histamine agonist | 0.088 0.011 CID_3007 | CID_3007 | |
| 0.082 | 0.032 | 0.094 | Phospholipase D inhibitor | 0.094 0.019 CID_3007 | CID_3007 | |
| 0.069 | 0.02 | 0.091 | Bombesin 2 receptor antagonist | 0.091 0.015 CID_3007 | CID_3007 | |
| 0.058 | 0.009 | 0.058 | Beta adrenoreceptor agonist | 0.052 0.014 CID_3007 | ||
| 0.124 | 0.078 | 0.173 | Vanilloid 1 agonist | 0.173 0.022 CID_3007 | CID_3007 | |
| 0.082 | 0.036 | 0.385 | Phenylalanine 4-hydroxylase inhibitor | 0.385 0.003 CID_3007 | CID_3007 | |
| 0.064 | 0.018 | 0.106 | Immunoglobulin Fc receptor antagonist | 0.106 0.004 CID_3007 | CID_3007 | |
| 0.059 | 0.014 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 CID_3007 | CID_3007 | |
| 0.055 | 0.01 | 0.055 | Potassium channel Kv1.1 blocker | 0.046 0.016 CID_3007 | ||
| 0.058 | 0.014 | 0.077 | Dipeptidyl peptidase IV inhibitor | 0.077 0.008 CID_3007 | CID_3007 | |
| 0.099 | 0.055 | 0.119 | Falcipain inhibitor | 0.119 0.045 CID_3007 | CID_3007 | |
| 0.095 | 0.051 | 0.122 | Glutamate release inhibitor | 0.122 0.02 CID_3007 | CID_3007 | |
| 0.088 | 0.045 | 0.088 | Caspase 7 inhibitor | |||
| 0.071 | 0.031 | 0.141 | Carbonic anhydrase stimulant | 0.141 0.012 CID_3007 | CID_3007 | |
| 0.07 | 0.029 | 0.078 | Cathepsin D inhibitor | 0.078 0.026 CID_3007 | CID_3007 | |
| 0.06 | 0.02 | 0.06 | Farnesyltransferase inhibitor | |||
| 0.156 | 0.116 | 0.156 | MAP kinase kinase 2 inhibitor | |||
| 0.176 | 0.137 | 0.28 | Nitric-oxide synthase stimulant | 0.28 0.017 CID_3007 | CID_3007 | |
| 0.053 | 0.015 | 0.056 | Plasmepsin II inhibitor | 0.056 0.014 CID_3007 | CID_3007 | |
| 0.085 | 0.048 | 0.093 | CC chemokine 5 receptor agonist | 0.093 0.032 CID_3007 | CID_3007 | |
| 0.093 | 0.057 | 0.113 | Falcipain 2 inhibitor | 0.113 0.045 CID_3007 | CID_3007 | |
| 0.096 | 0.061 | 0.096 | Protein kinase C mu inhibitor | |||
| 0.13 | 0.095 | 0.17 | Diuretic | 0.17 0.061 CID_3007 | CID_3007 | |
| 0.096 | 0.064 | 0.19 | Creatine kinase inhibitor | 0.19 0.012 CID_3007 | CID_3007 | |
| 0.086 | 0.054 | 0.086 | Histamine H2 receptor antagonist | 0.082 0.06 CID_3007 | ||
| 0.058 | 0.027 | 0.071 | Prolyl endopeptidase inhibitor | 0.071 0.015 CID_3007 | CID_3007 | |
| 0.053 | 0.022 | 0.064 | Oxytocin agonist | 0.064 0.014 CID_3007 | CID_3007 | |
| 0.035 | 0.005 | 0.035 | Acid ceramidase inhibitor | 0.031 0.008 CID_3007 | ||
| 0.112 | 0.082 | 0.13 | Cholinergic antagonist | 0.13 0.065 CID_3007 | CID_3007 | |
| 0.042 | 0.013 | 0.077 | Dipeptidyl peptidase II inhibitor | 0.077 0.005 CID_3007 | CID_3007 | |
| 0.076 | 0.046 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.044 CID_3007 | ||
| 0.049 | 0.02 | 0.059 | Melanocortin 1 antagonist | 0.059 0.017 CID_3007 | CID_3007 | |
| 0.108 | 0.079 | 0.112 | Caspase 3 inhibitor | 0.112 0.072 CID_3007 | CID_3007 | |
| 0.109 | 0.081 | 0.127 | Acetylcholine antagonist | 0.127 0.064 CID_3007 | CID_3007 | |
| 0.064 | 0.036 | 0.125 | Bombesin 1 receptor agonist | 0.125 0.012 CID_3007 | CID_3007 | |
| 0.095 | 0.069 | 0.179 | GABA C receptor rho-1 antagonist | 0.179 0.012 CID_3007 | CID_3007 | |
| 0.054 | 0.029 | 0.054 | Potassium channel (Inward rectifier) activator | 0.049 0.038 CID_3007 | ||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | 0.026 0.021 CID_3007 | ||
| 0.051 | 0.027 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.047 0.036 CID_3007 | ||
| 0.035 | 0.011 | 0.035 | Cathepsin K inhibitor | |||
| 0.047 | 0.024 | 0.074 | GHS receptor agonist | 0.074 0.008 CID_3007 | CID_3007 | |
| 0.094 | 0.071 | 0.131 | Anabolic | 0.131 0.03 CID_3007 | CID_3007 | |
| 0.085 | 0.062 | 0.142 | Granulocyte macrophage colony stimulating factor agonist | 0.142 0.007 CID_3007 | CID_3007 | |
| 0.057 | 0.034 | 0.131 | Ornithine carbamoyltransferase inhibitor | 0.131 0.011 CID_3007 | CID_3007 | |
| 0.053 | 0.031 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.076 0.011 CID_3007 | CID_3007 | |
| 0.084 | 0.063 | 0.194 | Opioid antagonist | 0.194 0.015 CID_3007 | CID_3007 | |
| 0.056 | 0.036 | 0.08 | Epithelial sodium channel blocker | 0.08 0.012 CID_3007 | CID_3007 | |
| 0.042 | 0.023 | 0.052 | Membrane dipeptidase inhibitor | 0.052 0.014 CID_3007 | CID_3007 | |
| 0.064 | 0.045 | 0.097 | Glucagon-like peptide 1 agonist | 0.097 0.023 CID_3007 | CID_3007 | |
| 0.177 | 0.158 | 0.271 | DNA synthesis inhibitor | 0.271 0.055 CID_3007 | CID_3007 | |
| 0.056 | 0.037 | 0.093 | Human rhinovirus A protease inhibitor | 0.093 0.019 CID_3007 | CID_3007 | |
| 0.094 | 0.076 | 0.175 | Carbonic anhydrase XV inhibitor | 0.175 0.023 CID_3007 | CID_3007 | |
| 0.057 | 0.039 | 0.206 | Argininosuccinate synthase inhibitor | 0.206 0.007 CID_3007 | CID_3007 | |
| 0.035 | 0.016 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.014 CID_3007 | CID_3007 | |
| 0.062 | 0.044 | 0.124 | NMDA receptor agonist | 0.124 0.012 CID_3007 | CID_3007 | |
| 0.072 | 0.054 | 0.184 | Glutamate dehydrogenase inhibitor | 0.184 0.011 CID_3007 | CID_3007 | |
| 0.059 | 0.042 | 0.081 | Cathepsin E inhibitor | 0.081 0.022 CID_3007 | CID_3007 | |
| 0.186 | 0.17 | 0.186 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.027 | 0.011 | 0.027 | Beta 1 adrenoreceptor agonist | 0.022 0.017 CID_3007 | ||
| 0.047 | 0.032 | 0.056 | Melanocortin antagonist | 0.056 0.023 CID_3007 | CID_3007 | |
| 0.043 | 0.028 | 0.053 | Melanocortin 4 antagonist | 0.053 0.022 CID_3007 | CID_3007 | |
| 0.033 | 0.019 | 0.08 | Endothelial nitric-oxide synthase inhibitor | 0.08 0.005 CID_3007 | CID_3007 | |
| 0.024 | 0.01 | 0.024 | Cathepsin S inhibitor | |||
| 0.032 | 0.019 | 0.034 | Plasmepsin I inhibitor | 0.034 0.017 CID_3007 | CID_3007 | |
| 0.04 | 0.028 | 0.094 | Dopamine D5 agonist | 0.094 0.005 CID_3007 | CID_3007 | |
| 0.027 | 0.015 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.009 CID_3007 | CID_3007 | |
| 0.031 | 0.02 | 0.032 | Peptide deformylase inhibitor | 0.032 0.019 CID_3007 | CID_3007 | |
| 0.051 | 0.041 | 0.078 | Nicotinic alpha3beta2 receptor antagonist | 0.078 0.013 CID_3007 | CID_3007 | |
| 0.178 | 0.167 | 0.271 | Transcription factor STAT3 inhibitor | 0.271 0.069 CID_3007 | CID_3007 | |
| 0.154 | 0.145 | 0.166 | Cyclic AMP phosphodiesterase inhibitor | 0.166 0.128 CID_3007 | CID_3007 | |
| 0.033 | 0.023 | 0.038 | Carboxypeptidase B inhibitor | 0.038 0.014 CID_3007 | CID_3007 | |
| 0.09 | 0.081 | 0.155 | Expectorant | 0.155 0.033 CID_3007 | CID_3007 | |
| 0.02 | 0.011 | 0.028 | Histamine H4 receptor agonist | 0.028 0.007 CID_3007 | CID_3007 | |
| 0.028 | 0.02 | 0.053 | Thrombin receptor antagonist | 0.053 0.008 CID_3007 | CID_3007 | |
| 0.087 | 0.078 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | 0.14 0.016 CID_3007 | CID_3007 | |
| 0.045 | 0.038 | 0.061 | Bombesin antagonist | 0.061 0.017 CID_3007 | CID_3007 | |
| 0.069 | 0.061 | 0.221 | CYP2A6 inhibitor | 0.221 0.005 CID_3007 | CID_3007 | |
| 0.027 | 0.019 | 0.037 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.037 0.008 CID_3007 | CID_3007 | |
| 0.114 | 0.106 | 0.473 | Peroxidase inhibitor | 0.473 0.012 CID_3007 | CID_3007 | |
| 0.122 | 0.114 | 0.162 | Phospholipase A2 inhibitor | 0.162 0.064 CID_3007 | CID_3007 | |
| 0.066 | 0.058 | 0.226 | Catalase inhibitor | 0.226 0.011 CID_3007 | CID_3007 | |
| 0.045 | 0.038 | 0.055 | Baculoviral IAP repeat-containing protein inhibitor | 0.055 0.01 CID_3007 | CID_3007 | |
| 0.038 | 0.032 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.054 | 0.048 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.073 0.023 CID_3007 | CID_3007 | |
| 0.072 | 0.066 | 0.138 | Chymotrypsin inhibitor | 0.138 0.02 CID_3007 | CID_3007 | |
| 0.064 | 0.057 | 0.305 | Histidine decarboxylase inhibitor | 0.305 0.006 CID_3007 | CID_3007 | |
| 0.051 | 0.045 | 0.068 | Angiotensin-converting enzyme inhibitor | 0.068 0.022 CID_3007 | CID_3007 | |
| 0.093 | 0.087 | 0.182 | Nav1.4 sodium channel blocker | 0.182 0.023 CID_3007 | CID_3007 | |
| 0.039 | 0.033 | 0.071 | Complement C3a chemotactic receptor antagonist | 0.071 0.017 CID_3007 | CID_3007 | |
| 0.024 | 0.02 | 0.041 | Vanilloid 2 agonist | 0.041 0.004 CID_3007 | CID_3007 | |
| 0.118 | 0.113 | 0.217 | Thrombolytic | 0.217 0.044 CID_3007 | CID_3007 | |
| 0.183 | 0.179 | 0.195 | MAP kinase kinase 3 inhibitor | 0.195 0.137 CID_3007 | CID_3007 | |
| 0.022 | 0.018 | 0.054 | Aminopeptidase P inhibitor | 0.054 0.004 CID_3007 | CID_3007 | |
| 0.019 | 0.016 | 0.034 | Integrin alpha4beta7 antagonist | 0.034 0.008 CID_3007 | CID_3007 | |
| 0.059 | 0.056 | 0.134 | Sphingosine 1-phosphate receptor 4 agonist | 0.134 0.012 CID_3007 | CID_3007 | |
| 0.126 | 0.123 | 0.18 | Melanin inhibitor | 0.18 0.051 CID_3007 | CID_3007 | |
| 0.079 | 0.077 | 0.13 | NADH dehydrogenase inhibitor | 0.13 0.024 CID_3007 | CID_3007 | |
| 0.045 | 0.044 | 0.063 | Cytokine production stimulant | 0.063 0.011 CID_3007 | CID_3007 | |
| 0.038 | 0.037 | 0.104 | Kainate receptor agonist | 0.104 0.003 CID_3007 | CID_3007 | |
| 0.032 | 0.031 | 0.032 | Histone deacetylase 7 inhibitor | |||
| 0.058 | 0.057 | 0.083 | Histone deacetylase SIRT3 inhibitor | 0.083 0.016 CID_3007 | CID_3007 | |
| 0.092 | 0.092 | 0.121 | Protein kinase C gamma inhibitor | 0.121 0.052 CID_3007 | CID_3007 | |
| 0.129 | 0.128 | 0.166 | Heat shock protein 70 antagonist | 0.166 0.021 CID_3007 | CID_3007 | |
| 0.133 | 0.133 | 0.354 | Anesthetic general | 0.354 0.023 CID_3007 | CID_3007 | |
| 0.036 | 0.036 | 0.082 | AMPA 4 receptor antagonist | 0.082 0.006 CID_3007 | CID_3007 | |
| 0.067 | 0.067 | 0.144 | Analgesic, opioid | 0.144 0.016 CID_3007 | CID_3007 | |
| 0.028 | 0.029 | 0.053 | Calcitonin receptor agonist | 0.053 0.016 CID_3007 | CID_3007 | |
| 0.038 | 0.038 | 0.048 | HIV-1 protease inhibitor | 0.048 0.023 CID_3007 | CID_3007 | |
| 0.101 | 0.101 | 0.115 | Sphingosine 1-phosphate receptor 2 agonist | 0.115 0.063 CID_3007 | CID_3007 | |
| 0.076 | 0.076 | 0.11 | Factor XII inhibitor | 0.11 0.03 CID_3007 | CID_3007 | |
| 0.045 | 0.045 | 0.05 | Collagenase inhibitor | 0.05 0.032 CID_3007 | CID_3007 | |
| 0.017 | 0.018 | 0.025 | Neurokinin 1 agonist | 0.025 0.012 CID_3007 | CID_3007 | |
| 0.023 | 0.024 | 0.036 | Lysine carboxypeptidase inhibitor | 0.036 0.012 CID_3007 | CID_3007 | |
| 0.014 | 0.017 | 0.034 | Aminopeptidase A inhibitor | 0.034 0.005 CID_3007 | CID_3007 | |
| 0.08 | 0.082 | 0.324 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.324 0.005 CID_3007 | CID_3007 | |
| 0.038 | 0.041 | 0.108 | Glycine transporter 2 inhibitor | 0.108 0.012 CID_3007 | CID_3007 | |
| 0.062 | 0.066 | 0.214 | Glutamate decarboxylase inhibitor | 0.214 0.006 CID_3007 | CID_3007 | |
| 0.025 | 0.028 | 0.045 | Trypsin II inhibitor | 0.045 0.011 CID_3007 | CID_3007 | |
| 0.083 | 0.087 | 0.186 | Carbonic anhydrase III inhibitor | 0.186 0.019 CID_3007 | CID_3007 | |
| 0.062 | 0.066 | 0.092 | Thrombin inhibitor | 0.092 0.031 CID_3007 | CID_3007 | |
| 0.05 | 0.054 | 0.095 | Kallikrein 1 inhibitor | 0.095 0.013 CID_3007 | CID_3007 | |
| 0.11 | 0.115 | 0.149 | Cell wall synthesis inhibitor | 0.149 0.067 CID_3007 | CID_3007 | |
| 0.037 | 0.042 | 0.055 | Neurotensin receptor antagonist | 0.055 0.025 CID_3007 | CID_3007 | |
| 0.123 | 0.128 | 0.182 | Interferon gamma antagonist | 0.182 0.049 CID_3007 | CID_3007 | |
| 0.026 | 0.031 | 0.074 | Growth hormone releasing factor agonist | 0.074 0.006 CID_3007 | CID_3007 | |
| 0.085 | 0.09 | 0.307 | Ferrochelatase inhibitor | 0.307 0.007 CID_3007 | CID_3007 | |
| 0.042 | 0.047 | 0.091 | Ribonucleoside-diphosphate reductase inhibitor | 0.091 0.021 CID_3007 | CID_3007 | |
| 0.054 | 0.06 | 0.168 | Opioid mu receptor antagonist | 0.168 0.014 CID_3007 | CID_3007 | |
| 0.028 | 0.034 | 0.065 | Arginase inhibitor | 0.065 0.009 CID_3007 | CID_3007 | |
| 0.018 | 0.024 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_3007 | CID_3007 | |
| 0.042 | 0.049 | 0.091 | Ribonucleotide reductase inhibitor | 0.091 0.023 CID_3007 | CID_3007 | |
| 0.044 | 0.051 | 0.085 | Acyl-CoA dehydrogenase inhibitor | 0.085 0.02 CID_3007 | CID_3007 | |
| 0.081 | 0.087 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.079 CID_3007 | CID_3007 | |
| 0.226 | 0.233 | 0.408 | Calcium channel L-type activator | 0.408 0.076 CID_3007 | CID_3007 | |
| 0.029 | 0.037 | 0.036 | Calpain 1 inhibitor | 0.036 0.016 CID_3007 | CID_3007 | |
| 0.087 | 0.095 | 0.189 | Adenylate kinase inhibitor | 0.189 0.017 CID_3007 | CID_3007 | |
| 0.018 | 0.026 | 0.029 | Protease (Human cytomegalovirus) inhibitor | 0.029 0.008 CID_3007 | CID_3007 | |
| 0.041 | 0.049 | 0.122 | Neuropeptide agonist | 0.122 0.022 CID_3007 | CID_3007 | |
| 0.044 | 0.053 | 0.122 | Aminopeptidase microsomal inhibitor | 0.122 0.013 CID_3007 | CID_3007 | |
| 0.127 | 0.137 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.158 0.026 CID_3007 | CID_3007 | |
| 0.024 | 0.034 | 0.035 | Purinergic P2Y15 antagonist | 0.035 0.01 CID_3007 | CID_3007 | |
| 0.047 | 0.058 | 0.195 | Opioid delta receptor antagonist | 0.195 0.012 CID_3007 | CID_3007 | |
| 0.075 | 0.086 | 0.091 | 3C-Like protease (SARS coronavirus) inhibitor | 0.091 0.044 CID_3007 | CID_3007 | |
| 0.028 | 0.039 | 0.043 | Bombesin 1 receptor antagonist | 0.043 0.019 CID_3007 | CID_3007 | |
| 0.016 | 0.027 | 0.022 | Geranylgeranyltransferase inhibitor | 0.022 0.016 CID_3007 | CID_3007 | |
| 0.015 | 0.026 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 CID_3007 | CID_3007 | |
| 0.038 | 0.05 | 0.05 | Metalloproteinase-3 inhibitor | 0.05 0.033 CID_3007 | CID_3007 | |
| 0.03 | 0.042 | 0.066 | Toll-Like receptor 2 agonist | 0.066 0.019 CID_3007 | CID_3007 | |
| 0.097 | 0.11 | 0.179 | Toll-Like receptor 2 antagonist | 0.179 0.034 CID_3007 | CID_3007 | |
| 0.035 | 0.048 | 0.045 | VCAM-1 antagonist | 0.045 0.015 CID_3007 | CID_3007 | |
| 0.035 | 0.048 | 0.044 | VCAM antagonist | 0.044 0.015 CID_3007 | CID_3007 | |
| 0.028 | 0.042 | 0.04 | Factor XIIIa inhibitor | 0.04 0.023 CID_3007 | CID_3007 | |
| 0.092 | 0.106 | 0.166 | Photosensitizer | 0.166 0.023 CID_3007 | CID_3007 | |
| 0.102 | 0.116 | 0.204 | Histone deacetylase SIRT1 inhibitor | 0.204 0.029 CID_3007 | CID_3007 | |
| 0.044 | 0.058 | 0.057 | Matrix metalloproteinase (membrane-type) inhibitor | 0.057 0.035 CID_3007 | CID_3007 | |
| 0.059 | 0.073 | 0.073 | Rho-associated kinase I inhibitor | 0.073 0.054 CID_3007 | CID_3007 | |
| 0.048 | 0.063 | 0.28 | 5 Hydroxytryptamine 2A agonist | 0.28 0.003 CID_3007 | CID_3007 | |
| 0.01 | 0.026 | 0.03 | Dipeptidyl peptidase VIII inhibitor | 0.03 0.005 CID_3007 | CID_3007 | |
| 0.029 | 0.045 | 0.041 | Cholecystokinin B agonist | 0.041 0.022 CID_3007 | CID_3007 | |
| 0.022 | 0.039 | 0.058 | Sirtuin 2 inhibitor | 0.058 0.01 CID_3007 | CID_3007 | |
| 0.043 | 0.06 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.016 CID_3007 | CID_3007 | |
| 0.034 | 0.051 | 0.044 | Sphingosine 1-phosphate receptor agonist | 0.044 0.031 CID_3007 | CID_3007 | |
| 0.025 | 0.042 | 0.033 | Phosphoglycerate kinase inhibitor | 0.033 0.027 CID_3007 | CID_3007 | |
| 0.014 | 0.032 | 0.048 | Integrin alpha4 antagonist | 0.048 0.012 CID_3007 | CID_3007 | |
| 0.033 | 0.051 | 0.064 | Nicotinic receptor alpha3 subunit antagonist | 0.064 0.017 CID_3007 | CID_3007 | |
| 0.06 | 0.078 | 0.066 | MDM2 inhibitor | 0.066 0.051 CID_3007 | CID_3007 | |
| 0.01 | 0.028 | 0.053 | Growth hormone release promoting | 0.053 0.005 CID_3007 | CID_3007 | |
| 0.03 | 0.049 | 0.052 | Endothelin-converting enzyme inhibitor | 0.052 0.029 CID_3007 | CID_3007 | |
| 0.005 | 0.024 | 0.01 | Melatonin 5 antagonist | 0.01 0.009 CID_3007 | CID_3007 | |
| 0.01 | 0.029 | 0.037 | Dipeptidyl peptidase IX inhibitor | 0.037 0.005 CID_3007 | CID_3007 | |
| 0.066 | 0.086 | 0.156 | Histamine N-methyltransferase inhibitor | 0.156 0.012 CID_3007 | CID_3007 | |
| 0.047 | 0.067 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.04 CID_3007 | CID_3007 | |
| 0.085 | 0.104 | 0.108 | Folate antagonist | 0.108 0.052 CID_3007 | CID_3007 | |
| 0.05 | 0.07 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.048 CID_3007 | CID_3007 | |
| 0.031 | 0.052 | 0.103 | Aminopeptidase N inhibitor | 0.103 0.012 CID_3007 | CID_3007 | |
| 0.027 | 0.048 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 CID_3007 | CID_3007 | |
| 0.007 | 0.028 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 CID_3007 | CID_3007 | |
| 0.028 | 0.049 | 0.041 | Erythropoietin receptor agonist | 0.041 0.028 CID_3007 | CID_3007 | |
| 0.033 | 0.056 | 0.042 | Dihydroorotase inhibitor | 0.042 0.035 CID_3007 | CID_3007 | |
| 0.037 | 0.06 | 0.203 | 5 Hydroxytryptamine 2 agonist | 0.203 0.004 CID_3007 | CID_3007 | |
| 0.019 | 0.042 | 0.027 | Calcium-sensing receptor agonist | 0.027 0.018 CID_3007 | CID_3007 | |
| 0.115 | 0.138 | 0.173 | GABA C receptor rho-2 antagonist | 0.173 0.048 CID_3007 | CID_3007 | |
| 0.044 | 0.067 | 0.176 | Protein kinase C iota inhibitor | 0.176 0.006 CID_3007 | CID_3007 | |
| 0.028 | 0.052 | 0.034 | Integrin alpha2 antagonist | 0.034 0.031 CID_3007 | CID_3007 | |
| 0.025 | 0.049 | 0.051 | Somatostatin 5 agonist | 0.051 0.012 CID_3007 | CID_3007 | |
| 0.06 | 0.084 | 0.159 | GABA aminotransferase inhibitor | 0.159 0.006 CID_3007 | CID_3007 | |
| 0.13 | 0.155 | 0.215 | Succinate dehydrogenase inhibitor | 0.215 0.038 CID_3007 | CID_3007 | |
| 0.115 | 0.14 | 0.194 | Sphingosine 1-phosphate receptor 5 antagonist | 0.194 0.014 CID_3007 | CID_3007 | |
| 0.011 | 0.037 | 0.063 | VLA-4 antagonist | 0.063 0.01 CID_3007 | CID_3007 | |
| 0.044 | 0.07 | 0.091 | Sphingosine 1-phosphate receptor 3 antagonist | 0.091 0.011 CID_3007 | CID_3007 | |
| 0.009 | 0.035 | 0.028 | Integrin beta7 antagonist | 0.028 0.01 CID_3007 | CID_3007 | |
| 0.009 | 0.035 | 0.025 | Melanocortin 3 antagonist | 0.025 0.022 CID_3007 | CID_3007 | |
| 0.042 | 0.068 | 0.125 | Sphingosine kinase 2 inhibitor | 0.125 0.004 CID_3007 | CID_3007 | |
| 0.024 | 0.051 | 0.062 | Protease activated receptor 1 antagonist | 0.062 0.026 CID_3007 | CID_3007 | |
| 0.015 | 0.042 | 0.052 | AMPA 3 receptor antagonist | 0.052 0.008 CID_3007 | CID_3007 | |
| 0.005 | 0.032 | 0.011 | Angiotensin AT2 receptor agonist | 0.011 0.006 CID_3007 | CID_3007 | |
| 0.031 | 0.058 | 0.056 | Antimetabolite | 0.056 0.028 CID_3007 | CID_3007 | |
| 0.053 | 0.08 | 0.063 | Potassium channel (ATP-sensitive) blocker | 0.063 0.055 CID_3007 | CID_3007 | |
| 0.028 | 0.056 | 0.074 | Tryptophan 5 hydroxylase inhibitor | 0.074 0.003 CID_3007 | CID_3007 | |
| 0.008 | 0.036 | 0.017 | CXC chemokine 4 receptor agonist | 0.017 0.009 CID_3007 | CID_3007 | |
| 0.018 | 0.046 | 0.037 | Renin inhibitor | 0.037 0.025 CID_3007 | CID_3007 | |
| 0.011 | 0.039 | 0.02 | Human T-cell leukemia virus type I protease inhibitor | 0.02 0.016 CID_3007 | CID_3007 | |
| 0.09 | 0.119 | 0.188 | Cyclooxygenase 3 inhibitor | 0.188 0.024 CID_3007 | CID_3007 | |
| 0.058 | 0.088 | 0.072 | Metalloproteinase-9 inhibitor | 0.072 0.052 CID_3007 | CID_3007 | |
| 0.025 | 0.055 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.023 CID_3007 | CID_3007 | |
| 0.024 | 0.054 | 0.037 | Carbonic anhydrase I stimulant | 0.037 0.027 CID_3007 | CID_3007 | |
| 0.06 | 0.091 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.107 0.01 CID_3007 | CID_3007 | |
| 0.032 | 0.062 | 0.044 | AMPA receptor antagonist | 0.044 0.038 CID_3007 | CID_3007 | |
| 0.087 | 0.118 | 0.13 | TRPA1 agonist | 0.13 0.048 CID_3007 | CID_3007 | |
| 0.028 | 0.06 | 0.049 | Sphingosine 1-phosphate receptor 1 agonist | 0.049 0.02 CID_3007 | CID_3007 | |
| 0.054 | 0.086 | 0.065 | Prolactin release inhibitor | 0.065 0.035 CID_3007 | CID_3007 | |
| 0.024 | 0.056 | 0.034 | GHS receptor antagonist | 0.034 0.019 CID_3007 | CID_3007 | |
| 0.031 | 0.064 | 0.124 | Opioid mu receptor agonist | 0.124 0.009 CID_3007 | CID_3007 | |
| 0.153 | 0.187 | 0.261 | 5 Hydroxytryptamine 1E antagonist | 0.261 0.063 CID_3007 | CID_3007 | |
| 0.017 | 0.051 | 0.1 | Glutamate (mGluR1) agonist | 0.1 0.004 CID_3007 | CID_3007 | |
| 0.076 | 0.109 | 0.119 | Alpha 2b adrenoreceptor antagonist | 0.119 0.059 CID_3007 | CID_3007 | |
| 0.013 | 0.047 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.011 CID_3007 | CID_3007 | |
| 0.05 | 0.083 | 0.1 | Sirtuin 1 inhibitor | 0.1 0.022 CID_3007 | CID_3007 | |
| 0.034 | 0.068 | 0.083 | Plasminogen activator inhibitor | 0.083 0.024 CID_3007 | CID_3007 | |
| 0.03 | 0.064 | 0.065 | Plasmin inhibitor | 0.065 0.026 CID_3007 | CID_3007 | |
| 0.134 | 0.168 | 0.268 | Antiamyloidogenic | 0.268 0.063 CID_3007 | CID_3007 | |
| 0.031 | 0.066 | 0.036 | Integrin alpha1beta1 antagonist | 0.036 0.033 CID_3007 | CID_3007 | |
| 0.019 | 0.055 | 0.037 | Motilin receptor antagonist | 0.037 0.009 CID_3007 | CID_3007 | |
| 0.039 | 0.075 | 0.054 | Carbonic anhydrase II stimulant | 0.054 0.032 CID_3007 | CID_3007 | |
| 0.03 | 0.066 | 0.061 | Mannosidase inhibitor | 0.061 0.016 CID_3007 | CID_3007 | |
| 0.089 | 0.127 | 0.174 | Interleukin 8 antagonist | 0.174 0.021 CID_3007 | CID_3007 | |
| 0.018 | 0.055 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 CID_3007 | CID_3007 | |
| 0.026 | 0.064 | 0.056 | Growth hormone release inhibitor | 0.056 0.018 CID_3007 | CID_3007 | |
| 0.009 | 0.048 | 0.023 | Growth hormone releasing factor antagonist | 0.023 0.017 CID_3007 | CID_3007 | |
| 0.048 | 0.088 | 0.161 | Porphobilinogen synthase inhibitor | 0.161 0.018 CID_3007 | CID_3007 | |
| 0.04 | 0.08 | 0.056 | Vanilloid 2 antagonist | 0.056 0.029 CID_3007 | CID_3007 | |
| 0.012 | 0.052 | 0.074 | Glutamate (mGluR1a) agonist | 0.074 0.004 CID_3007 | CID_3007 | |
| 0.021 | 0.06 | 0.065 | Somatostatin 1 antagonist | 0.065 0.013 CID_3007 | CID_3007 | |
| 0.087 | 0.126 | 0.162 | Cell adhesion inhibitor | 0.162 0.04 CID_3007 | CID_3007 | |
| 0.039 | 0.079 | 0.095 | Bombesin 3 receptor antagonist | 0.095 0.013 CID_3007 | CID_3007 | |
| 0.06 | 0.101 | 0.096 | Myeloperoxidase inhibitor | 0.096 0.041 CID_3007 | CID_3007 | |
| 0.013 | 0.053 | 0.023 | Bombesin agonist | 0.023 0.015 CID_3007 | CID_3007 | |
| 0.012 | 0.053 | 0.032 | Tryptophan hydroxylase 1 inhibitor | 0.032 0.003 CID_3007 | CID_3007 | |
| 0.045 | 0.087 | 0.1 | Alpha adrenoreceptor agonist | 0.1 0.028 CID_3007 | CID_3007 | |
| 0.05 | 0.092 | 0.074 | Trypsin inhibitor | 0.074 0.03 CID_3007 | CID_3007 | |
| 0.026 | 0.068 | 0.061 | Adenosine deaminase inhibitor | 0.061 0.02 CID_3007 | CID_3007 | |
| 0.043 | 0.086 | 0.117 | Sphingosine kinase inhibitor | 0.117 0.005 CID_3007 | CID_3007 | |
| 0.03 | 0.073 | 0.046 | AICAR transformylase inhibitor | 0.046 0.027 CID_3007 | CID_3007 | |
| 0.04 | 0.083 | 0.07 | Matrix metalloproteinase inhibitor | 0.07 0.044 CID_3007 | CID_3007 | |
| 0.038 | 0.081 | 0.14 | Carbamoyl phosphate synthetase inhibitor | 0.14 0.012 CID_3007 | CID_3007 | |
| 0.034 | 0.078 | 0.088 | Dopamine uptake inhibitor | 0.088 0.022 CID_3007 | CID_3007 | |
| 0.029 | 0.073 | 0.102 | Opioid agonist | 0.102 0.013 CID_3007 | CID_3007 | |
| 0.011 | 0.055 | 0.017 | Bombesin 3 receptor agonist | 0.017 0.016 CID_3007 | CID_3007 | |
| 0.039 | 0.085 | 0.08 | Neutrophil collagenase inhibitor | 0.08 0.032 CID_3007 | CID_3007 | |
| 0.066 | 0.112 | 0.136 | Triose-phosphate isomerase inhibitor | 0.136 0.024 CID_3007 | CID_3007 | |
| 0.062 | 0.108 | 0.111 | Glutathione S-transferase inhibitor | 0.111 0.028 CID_3007 | CID_3007 | |
| 0.013 | 0.058 | 0.026 | Somatostatin 4 antagonist | 0.026 0.014 CID_3007 | CID_3007 | |
| 0.028 | 0.074 | 0.086 | Sphingosine kinase 1 inhibitor | 0.086 0.005 CID_3007 | CID_3007 | |
| 0.068 | 0.115 | 0.135 | UDP-glucose 4-epimerase inhibitor | 0.135 0.035 CID_3007 | CID_3007 | |
| 0.046 | 0.093 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | 0.08 0.017 CID_3007 | CID_3007 | |
| 0.027 | 0.074 | 0.075 | Glutamate (mGluR8) agonist | 0.075 0.004 CID_3007 | CID_3007 | |
| 0.047 | 0.095 | 0.058 | Caspase 9 inhibitor | 0.058 0.052 CID_3007 | CID_3007 | |
| 0.075 | 0.123 | 0.179 | 5 Hydroxytryptamine 2B antagonist | 0.179 0.031 CID_3007 | CID_3007 | |
| 0.023 | 0.071 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 CID_3007 | CID_3007 | |
| 0.017 | 0.066 | 0.07 | Fumarate hydratase inhibitor | 0.07 0.008 CID_3007 | CID_3007 | |
| 0.015 | 0.065 | 0.081 | Kainate receptor 2 antagonist | 0.081 0.006 CID_3007 | CID_3007 | |
| 0.019 | 0.07 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.025 CID_3007 | CID_3007 | |
| 0.034 | 0.085 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.059 0.017 CID_3007 | CID_3007 | |
| 0.027 | 0.079 | 0.153 | 5 Hydroxytryptamine 2B agonist | 0.153 0.003 CID_3007 | CID_3007 | |
| 0.063 | 0.116 | 0.093 | MAP kinase kinase 7 inhibitor | 0.093 0.02 CID_3007 | CID_3007 | |
| 0.05 | 0.104 | 0.121 | Protein kinase B gamma inhibitor | 0.121 0.025 CID_3007 | CID_3007 | |
| 0.019 | 0.073 | 0.081 | Diamine oxidase inhibitor | 0.081 0.005 CID_3007 | CID_3007 | |
| 0.047 | 0.101 | 0.075 | Interferon inducer | 0.075 0.029 CID_3007 | CID_3007 | |
| 0.009 | 0.064 | 0.059 | Somatostatin 2 antagonist | 0.059 0.012 CID_3007 | CID_3007 | |
| 0.03 | 0.086 | 0.101 | Glutamate (mGluR4) antagonist | 0.101 0.005 CID_3007 | CID_3007 | |
| 0.017 | 0.072 | 0.037 | Integrin antagonist | 0.037 0.032 CID_3007 | CID_3007 | |
| 0.014 | 0.071 | 0.029 | Trypsin I inhibitor | 0.029 0.027 CID_3007 | CID_3007 | |
| 0.007 | 0.064 | 0.04 | AMPA 1 receptor antagonist | 0.04 0.015 CID_3007 | CID_3007 | |
| 0.013 | 0.07 | 0.02 | Toll-Like receptor 8 agonist | 0.02 0.014 CID_3007 | CID_3007 | |
| 0.051 | 0.108 | 0.13 | Glutamate (mGluR6) antagonist | 0.13 0.005 CID_3007 | CID_3007 | |
| 0.055 | 0.113 | 0.1 | Glycine receptor antagonist | 0.1 0.032 CID_3007 | CID_3007 | |
| 0.025 | 0.082 | 0.054 | Matrix metalloproteinase 1 inhibitor | 0.054 0.036 CID_3007 | CID_3007 | |
| 0.029 | 0.087 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.06 0.008 CID_3007 | CID_3007 | |
| 0.006 | 0.064 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_3007 | CID_3007 | |
| 0.015 | 0.074 | 0.03 | Thyroid hormone agonist | 0.03 0.013 CID_3007 | CID_3007 | |
| 0.022 | 0.08 | 0.114 | Glutamate (mGluR3) antagonist | 0.114 0.004 CID_3007 | CID_3007 | |
| 0.073 | 0.132 | 0.175 | Mucolytic | 0.175 0.021 CID_3007 | CID_3007 | |
| 0.068 | 0.128 | 0.104 | Protein kinase C zeta inhibitor | 0.104 0.046 CID_3007 | CID_3007 | |
| 0.081 | 0.141 | 0.143 | Aldehyde dehydrogenase inhibitor | 0.143 0.052 CID_3007 | CID_3007 | |
| 0.012 | 0.074 | 0.029 | Urotensin II agonist | 0.029 0.016 CID_3007 | CID_3007 | |
| 0.05 | 0.112 | 0.081 | Metalloproteinase-2 inhibitor | 0.081 0.052 CID_3007 | CID_3007 | |
| 0.071 | 0.134 | 0.158 | Histone deacetylase class III inhibitor | 0.158 0.038 CID_3007 | CID_3007 | |
| 0.015 | 0.078 | 0.054 | Methionyl aminopeptidase 1 inhibitor | 0.054 0.005 CID_3007 | CID_3007 | |
| 0.036 | 0.099 | 0.133 | Phosphofructokinase-1 inhibitor | 0.133 0.022 CID_3007 | CID_3007 | |
| 0.012 | 0.076 | 0.036 | Plasma kallikrein inhibitor | 0.036 0.021 CID_3007 | CID_3007 | |
| 0.028 | 0.092 | 0.047 | Adenylate cyclase 1 inhibitor | 0.047 0.031 CID_3007 | CID_3007 | |
| 0.019 | 0.084 | 0.027 | Hedgehog signaling activator | 0.027 0.021 CID_3007 | CID_3007 | |
| 0.058 | 0.125 | 0.073 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.064 CID_3007 | CID_3007 | |
| 0.087 | 0.155 | 0.157 | Transcription factor STAT6 inhibitor | 0.157 0.019 CID_3007 | CID_3007 | |
| 0.027 | 0.095 | 0.089 | Glutamate (mGluR1) antagonist | 0.089 0.02 CID_3007 | CID_3007 | |
| 0.008 | 0.076 | 0.021 | Telomerase stimulant | 0.021 0.006 CID_3007 | CID_3007 | |
| 0.035 | 0.103 | 0.068 | Alpha 2 adrenoreceptor agonist | 0.068 0.034 CID_3007 | CID_3007 | |
| 0.156 | 0.224 | 0.288 | Transcription factor STAT inhibitor | 0.288 0.063 CID_3007 | CID_3007 | |
| 0.092 | 0.16 | 0.143 | Neurotrophic factor | 0.143 0.066 CID_3007 | CID_3007 | |
| 0.025 | 0.096 | 0.044 | Adenosine uptake inhibitor | 0.044 0.007 CID_3007 | CID_3007 | |
| 0.053 | 0.124 | 0.098 | Opioid kappa receptor antagonist | 0.098 0.036 CID_3007 | CID_3007 | |
| 0.023 | 0.095 | 0.047 | Leukocyte elastase inhibitor | 0.047 0.026 CID_3007 | CID_3007 | |
| 0.044 | 0.116 | 0.108 | Nicotinic alpha4beta2 receptor antagonist | 0.108 0.025 CID_3007 | CID_3007 | |
| 0.028 | 0.101 | 0.127 | Alcohol oxidase inhibitor | 0.127 0.013 CID_3007 | CID_3007 | |
| 0.051 | 0.124 | 0.091 | Interferon agonist | 0.091 0.037 CID_3007 | CID_3007 | |
| 0.025 | 0.099 | 0.037 | Thymidine kinase inhibitor | 0.037 0.035 CID_3007 | CID_3007 | |
| 0.05 | 0.125 | 0.064 | Calcium channel P-type blocker | 0.064 0.042 CID_3007 | CID_3007 | |
| 0.065 | 0.139 | 0.197 | Cystathionine beta-synthase inhibitor | 0.197 0.025 CID_3007 | CID_3007 | |
| 0.016 | 0.091 | 0.066 | Opioid delta receptor agonist | 0.066 0.008 CID_3007 | CID_3007 | |
| 0.003 | 0.079 | 0.018 | Glutamate (mGluR6) agonist | 0.018 0.005 CID_3007 | CID_3007 | |
| 0.006 | 0.082 | 0.017 | Cyclin T1 inhibitor | 0.017 0.015 CID_3007 | CID_3007 | |
| 0.017 | 0.093 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.03 CID_3007 | CID_3007 | |
| 0.046 | 0.123 | 0.085 | Acetylcholine nicotinic antagonist | 0.085 0.05 CID_3007 | CID_3007 | |
| 0.049 | 0.126 | 0.08 | Exportin-1 inhibitor | 0.08 0.026 CID_3007 | CID_3007 | |
| 0.024 | 0.102 | 0.05 | Kallikrein inhibitor | 0.05 0.03 CID_3007 | CID_3007 | |
| 0.014 | 0.094 | 0.077 | Kainate receptor antagonist | 0.077 0.01 CID_3007 | CID_3007 | |
| 0.046 | 0.126 | 0.135 | 5 Hydroxytryptamine 2C antagonist | 0.135 0.031 CID_3007 | CID_3007 | |
| 0.03 | 0.11 | 0.077 | Aconitate hydratase inhibitor | 0.077 0.015 CID_3007 | CID_3007 | |
| 0.063 | 0.144 | 0.14 | 5 Hydroxytryptamine 3A agonist | 0.14 0.041 CID_3007 | CID_3007 | |
| 0.033 | 0.114 | 0.043 | Heme oxygenase inhibitor | 0.043 0.03 CID_3007 | CID_3007 | |
| 0.014 | 0.097 | 0.028 | Somatostatin agonist | 0.028 0.026 CID_3007 | CID_3007 | |
| 0.006 | 0.09 | 0.029 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 CID_3007 | CID_3007 | |
| 0.048 | 0.133 | 0.121 | Glycine receptor agonist | 0.121 0.012 CID_3007 | CID_3007 | |
| 0.037 | 0.122 | 0.091 | Purinergic P2X1 antagonist | 0.091 0.02 CID_3007 | CID_3007 | |
| 0.004 | 0.09 | 0.037 | Kainate receptor 1 antagonist | 0.037 0.008 CID_3007 | CID_3007 | |
| 0.011 | 0.099 | 0.03 | Histamine H3 receptor agonist | 0.03 0.018 CID_3007 | CID_3007 | |
| 0.009 | 0.096 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.013 CID_3007 | CID_3007 | |
| 0.024 | 0.112 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | 0.057 0.009 CID_3007 | CID_3007 | |
| 0.049 | 0.138 | 0.093 | Carbonic anhydrase VI inhibitor | 0.093 0.044 CID_3007 | CID_3007 | |
| 0.017 | 0.108 | 0.096 | NMDA 2A receptor antagonist | 0.096 0.014 CID_3007 | CID_3007 | |
| 0.017 | 0.109 | 0.036 | Angiotensin II receptor antagonist | 0.036 0.02 CID_3007 | CID_3007 | |
| 0.049 | 0.141 | 0.111 | Keratolytic | 0.111 0.025 CID_3007 | CID_3007 | |
| 0.008 | 0.1 | 0.018 | Somatostatin 3 antagonist | 0.018 0.016 CID_3007 | CID_3007 | |
| 0.084 | 0.178 | 0.323 | Angiogenesis stimulant | 0.323 0.041 CID_3007 | CID_3007 | |
| 0.011 | 0.107 | 0.027 | Nicotinic acid receptor 2 antagonist | 0.027 0.018 CID_3007 | CID_3007 | |
| 0.034 | 0.131 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.059 0.032 CID_3007 | CID_3007 | |
| 0.067 | 0.164 | 0.137 | Microtubule formation inhibitor | 0.137 0.045 CID_3007 | CID_3007 | |
| 0.018 | 0.115 | 0.041 | Angiotensin AT1 receptor antagonist | 0.041 0.031 CID_3007 | CID_3007 | |
| 0.053 | 0.15 | 0.119 | 5 Hydroxytryptamine 2 antagonist | 0.119 0.059 CID_3007 | CID_3007 | |
| 0.059 | 0.157 | 0.09 | Polo-like kinase-1 inhibitor | 0.09 0.061 CID_3007 | CID_3007 | |
| 0.026 | 0.124 | 0.045 | GABA B receptor antagonist | 0.045 0.027 CID_3007 | CID_3007 | |
| 0.017 | 0.116 | 0.06 | Carbonic anhydrase VB inhibitor | 0.06 0.035 CID_3007 | CID_3007 | |
| 0.009 | 0.108 | 0.037 | AMPA 2 receptor antagonist | 0.037 0.016 CID_3007 | CID_3007 | |
| 0.01 | 0.109 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 CID_3007 | CID_3007 | |
| 0.013 | 0.114 | 0.024 | ICAM 1 antagonist | 0.024 0.013 CID_3007 | CID_3007 | |
| 0.025 | 0.126 | 0.085 | NMDA receptor glycine site agonist | 0.085 0.025 CID_3007 | CID_3007 | |
| 0.027 | 0.128 | 0.113 | Biliverdin reductase inhibitor | 0.113 0.015 CID_3007 | CID_3007 | |
| 0.007 | 0.109 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 CID_3007 | CID_3007 | |
| 0.097 | 0.2 | 0.185 | DNA methylase inhibitor | 0.185 0.089 CID_3007 | CID_3007 | |
| 0.018 | 0.12 | 0.038 | GABA uptake inhibitor | 0.038 0.029 CID_3007 | CID_3007 | |
| 0.049 | 0.153 | 0.122 | Alcohol dehydrogenase inhibitor | 0.122 0.033 CID_3007 | CID_3007 | |
| 0.027 | 0.133 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.037 CID_3007 | CID_3007 | |
| 0.021 | 0.128 | 0.082 | 5 Hydroxytryptamine uptake inhibitor | 0.082 0.033 CID_3007 | CID_3007 | |
| 0.049 | 0.158 | 0.074 | Neuropeptide Y antagonist | 0.074 0.069 CID_3007 | CID_3007 | |
| 0.027 | 0.136 | 0.049 | HCV NS3/NS4A protease inhibitor | 0.049 0.035 CID_3007 | CID_3007 | |
| 0.014 | 0.126 | 0.034 | Nicotinic receptor beta4 subunit antagonist | 0.034 0.03 CID_3007 | CID_3007 | |
| 0.011 | 0.123 | 0.047 | Kinesin antagonist | 0.047 0.018 CID_3007 | CID_3007 | |
| 0.011 | 0.123 | 0.047 | Kinesin-like protein 1 inhibitor | 0.047 0.018 CID_3007 | CID_3007 | |
| 0.021 | 0.134 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.029 CID_3007 | CID_3007 | |
| 0.06 | 0.173 | 0.084 | Vanilloid agonist | 0.084 0.06 CID_3007 | CID_3007 | |
| 0.03 | 0.144 | 0.137 | Adrenaline uptake inhibitor | 0.137 0.011 CID_3007 | CID_3007 | |
| 0.015 | 0.129 | 0.029 | Complement factor 1s inhibitor | 0.029 0.009 CID_3007 | CID_3007 | |
| 0.011 | 0.125 | 0.052 | AMPA receptor agonist | 0.052 0.008 CID_3007 | CID_3007 | |
| 0.019 | 0.135 | 0.069 | NMDA receptor subunit 3B antagonist | 0.069 0.016 CID_3007 | CID_3007 | |
| 0.032 | 0.149 | 0.078 | Na+ K+ transporting ATPase inhibitor | 0.078 0.053 CID_3007 | CID_3007 | |
| 0.03 | 0.147 | 0.078 | 5 Hydroxytryptamine 2A antagonist | 0.078 0.06 CID_3007 | CID_3007 | |
| 0.021 | 0.138 | 0.106 | Dopamine transporter inhibitor | 0.106 0.01 CID_3007 | CID_3007 | |
| 0.006 | 0.124 | 0.018 | Complement factor D inhibitor | 0.018 0.014 CID_3007 | CID_3007 | |
| 0.056 | 0.175 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 CID_3007 | CID_3007 | |
| 0.058 | 0.18 | 0.122 | Alkylator | 0.122 0.066 CID_3007 | CID_3007 | |
| 0.087 | 0.21 | 0.15 | DNA methyltransferase I inhibitor | 0.15 0.104 CID_3007 | CID_3007 | |
| 0.013 | 0.139 | 0.068 | NMDA receptor subunit 3A antagonist | 0.068 0.015 CID_3007 | CID_3007 | |
| 0.097 | 0.224 | 0.196 | Non-steroidal antiinflammatory agent | 0.196 0.075 CID_3007 | CID_3007 | |
| 0.12 | 0.248 | 0.192 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.192 0.079 CID_3007 | CID_3007 | |
| 0.057 | 0.188 | 0.085 | D-Ala-D-Ala ligase inhibitor | 0.085 0.055 CID_3007 | CID_3007 | |
| 0.103 | 0.233 | 0.157 | ATPase inhibitor | 0.157 0.089 CID_3007 | CID_3007 | |
| 0.026 | 0.158 | 0.071 | Neuronal nicotinic receptor antagonist | 0.071 0.044 CID_3007 | CID_3007 | |
| 0.089 | 0.222 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | 0.12 0.082 CID_3007 | CID_3007 | |
| 0.026 | 0.161 | 0.053 | Histamine H4 receptor antagonist | 0.053 0.026 CID_3007 | CID_3007 | |
| 0.021 | 0.157 | 0.069 | Cyclin A1 inhibitor | 0.069 0.023 CID_3007 | CID_3007 | |
| 0.052 | 0.188 | 0.103 | Bile acid receptor antagonist | 0.103 0.042 CID_3007 | CID_3007 | |
| 0.049 | 0.185 | 0.093 | GABA B receptor agonist | 0.093 0.022 CID_3007 | CID_3007 | |
| 0.012 | 0.149 | 0.033 | 5 Hydroxytryptamine 6 agonist | 0.033 0.013 CID_3007 | CID_3007 | |
| 0.025 | 0.164 | 0.088 | Glutamate (mGluR group III) antagonist | 0.088 0.006 CID_3007 | CID_3007 | |
| 0.011 | 0.154 | 0.038 | Factor VIIa inhibitor | 0.038 0.027 CID_3007 | CID_3007 | |
| 0.126 | 0.27 | 0.233 | RNA-directed DNA polymerase inhibitor | 0.233 0.062 CID_3007 | CID_3007 | |
| 0.009 | 0.154 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 CID_3007 | CID_3007 | |
| 0.083 | 0.229 | 0.268 | Interleukin antagonist | 0.268 0.055 CID_3007 | CID_3007 | |
| 0.076 | 0.223 | 0.169 | Arachidonic acid antagonist | 0.169 0.067 CID_3007 | CID_3007 | |
| 0.046 | 0.194 | 0.084 | Cell adhesion molecule inhibitor | 0.084 0.048 CID_3007 | CID_3007 | |
| 0.035 | 0.185 | 0.078 | Protein kinase A inhibitor | 0.078 0.062 CID_3007 | CID_3007 | |
| 0.015 | 0.165 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 CID_3007 | CID_3007 | |
| 0.013 | 0.164 | 0.042 | Growth hormone secretagogue receptor antagonist | 0.042 0.021 CID_3007 | CID_3007 | |
| 0.013 | 0.164 | 0.067 | Glutamate (mGluR group I) agonist | 0.067 0.018 CID_3007 | CID_3007 | |
| 0.069 | 0.22 | 0.175 | Anticoagulant | 0.175 0.063 CID_3007 | CID_3007 | |
| 0.032 | 0.186 | 0.12 | Protein kinase B alpha inhibitor | 0.12 0.018 CID_3007 | CID_3007 | |
| 0.09 | 0.245 | 0.156 | CF transmembrane conductance regulator agonist | 0.156 0.066 CID_3007 | CID_3007 | |
| 0.057 | 0.214 | 0.091 | Hematopoietic | 0.091 0.047 CID_3007 | CID_3007 | |
| 0.068 | 0.227 | 0.132 | Protein kinase stimulant | 0.132 0.082 CID_3007 | CID_3007 | |
| 0.095 | 0.256 | 0.243 | Neurotrophic factor enhancer | 0.243 0.042 CID_3007 | CID_3007 | |
| 0.027 | 0.191 | 0.073 | Histone deacetylase SIRT2 inhibitor | 0.073 0.051 CID_3007 | CID_3007 | |
| 0.103 | 0.27 | 0.204 | DNA damaging | 0.204 0.112 CID_3007 | CID_3007 | |
| 0.022 | 0.188 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.038 CID_3007 | CID_3007 | |
| 0.014 | 0.182 | 0.046 | Glutamate (mGluR5) agonist | 0.046 0.032 CID_3007 | CID_3007 | |
| 0.016 | 0.184 | 0.593 | 5 Hydroxytryptamine agonist | 0.593 0.004 CID_3007 | CID_3007 | |
| 0.104 | 0.275 | 0.146 | Catenin beta inhibitor | 0.146 0.116 CID_3007 | CID_3007 | |
| 0.05 | 0.226 | 0.103 | Electrolyte absorption antagonist | 0.103 0.053 CID_3007 | CID_3007 | |
| 0.005 | 0.181 | 0.041 | Somatostatin 5 antagonist | 0.041 0.018 CID_3007 | CID_3007 | |
| 0.086 | 0.265 | 0.206 | 3C-like protease (Human coronavirus) inhibitor | 0.206 0.048 CID_3007 | CID_3007 | |
| 0.03 | 0.21 | 0.054 | Pregnane X receptor antagonist | 0.054 0.049 CID_3007 | CID_3007 | |
| 0.029 | 0.209 | 0.132 | NMDA receptor antagonist | 0.132 0.03 CID_3007 | CID_3007 | |
| 0.01 | 0.192 | 0.072 | Urokinase inhibitor | 0.072 0.024 CID_3007 | CID_3007 | |
| 0.041 | 0.224 | 0.098 | Cholesterol synthesis inhibitor | 0.098 0.09 CID_3007 | CID_3007 | |
| 0.031 | 0.215 | 0.113 | Glutamate (mGluR7) antagonist | 0.113 0.005 CID_3007 | CID_3007 | |
| 0.019 | 0.204 | 0.063 | Glutamate (mGluR group III) agonist | 0.063 0.017 CID_3007 | CID_3007 | |
| 0.122 | 0.31 | 0.2 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.2 0.157 CID_3007 | CID_3007 | |
| 0.072 | 0.262 | 0.158 | Anticonvulsant | 0.158 0.12 CID_3007 | CID_3007 | |
| 0.038 | 0.241 | 0.144 | HIV-1 integrase (Overall Integration) inhibitor | 0.144 0.028 CID_3007 | CID_3007 | |
| 0.015 | 0.222 | 0.061 | 5 Hydroxytryptamine 1D antagonist | 0.061 0.048 CID_3007 | CID_3007 | |
| 0.005 | 0.212 | 0.037 | Methionyl aminopeptidase 2 inhibitor | 0.037 0.01 CID_3007 | CID_3007 | |
| 0.026 | 0.235 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.046 CID_3007 | CID_3007 | |
| 0.046 | 0.257 | 0.102 | Beta amyloid protein antagonist | 0.102 0.087 CID_3007 | CID_3007 | |
| 0.033 | 0.248 | 0.107 | Urease inhibitor | 0.107 0.059 CID_3007 | CID_3007 | |
| 0.018 | 0.233 | 0.052 | Glutamate (mGluR8) antagonist | 0.052 0.008 CID_3007 | CID_3007 | |
| 0.126 | 0.343 | 0.222 | Antibacterial | 0.222 0.205 CID_3007 | CID_3007 | |
| 0.024 | 0.242 | 0.057 | 5 Hydroxytryptamine 3 agonist | 0.057 0.055 CID_3007 | CID_3007 | |
| 0.023 | 0.24 | 0.136 | Monophenol monooxygenase inhibitor | 0.136 0.053 CID_3007 | CID_3007 | |
| 0.043 | 0.261 | 0.144 | Amylase inhibitor | 0.144 0.067 CID_3007 | CID_3007 | |
| 0.023 | 0.245 | 0.059 | I kappa B kinase 2 inhibitor | 0.059 0.049 CID_3007 | CID_3007 | |
| 0.005 | 0.227 | 0.054 | Leukotriene A4 hydrolase inhibitor | 0.054 0.018 CID_3007 | CID_3007 | |
| 0.123 | 0.351 | 0.408 | Histamine release inhibitor | 0.408 0.072 CID_3007 | CID_3007 | |
| 0.056 | 0.286 | 0.155 | LIM domain kinase 1 inhibitor | 0.155 0.093 CID_3007 | CID_3007 | |
| 0.075 | 0.314 | 0.123 | Pregnane X receptor agonist | 0.123 0.122 CID_3007 | CID_3007 | |
| 0.074 | 0.318 | 0.304 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.304 0.038 CID_3007 | CID_3007 | |
| 0.083 | 0.339 | 0.212 | Hypoglycemic | 0.212 0.101 CID_3007 | CID_3007 | |
| 0.046 | 0.303 | 0.113 | Antibacterial (Helicobacter pylori) | 0.113 0.093 CID_3007 | CID_3007 | |
| 0.013 | 0.28 | 0.04 | Glutamate (mGluR4) agonist | 0.04 0.016 CID_3007 | CID_3007 | |
| 0.013 | 0.285 | 0.108 | Glutamate receptor agonist | 0.108 0.032 CID_3007 | CID_3007 | |
| 0.14 | 0.423 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.148 CID_3007 | CID_3007 | |
| 0.063 | 0.349 | 0.113 | DNA repair enzyme inhibitor | 0.113 0.088 CID_3007 | CID_3007 | |
| 0.071 | 0.36 | 0.155 | Focal adhesion kinase 2 inhibitor | 0.155 0.123 CID_3007 | CID_3007 | |
| 0.005 | 0.314 | 0.08 | NMDA 2 receptor antagonist | 0.08 0.044 CID_3007 | CID_3007 | |
| 0.004 | 0.317 | 0.035 | Glutamate (mGluR group II) antagonist | 0.035 0.031 CID_3007 | CID_3007 | |
| 0.041 | 0.358 | 0.132 | Cytokine production inhibitor | 0.132 0.078 CID_3007 | CID_3007 | |
| 0.035 | 0.362 | 0.144 | Pyruvate kinase inhibitor | 0.144 0.121 CID_3007 | CID_3007 | |
| 0.06 | 0.388 | 0.139 | Tumour necrosis factor antagonist | 0.139 0.115 CID_3007 | CID_3007 | |
| 0.005 | 0.343 | 0.314 | 5 Hydroxytryptamine 2C agonist | 0.314 0.004 CID_3007 | CID_3007 | |
| 0.046 | 0.389 | 0.171 | Platelet antagonist | 0.171 0.125 CID_3007 | CID_3007 | |
| 0.023 | 0.428 | 0.207 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.207 0.048 CID_3007 | CID_3007 | |
| 0.031 | 0.441 | 0.124 | Mannose-6-phosphate isomerase inhibitor | 0.124 0.095 CID_3007 | CID_3007 | |
| 0.079 | 0.508 | 0.224 | Apoptosis antagonist | 0.224 0.153 CID_3007 | CID_3007 | |
| 0.068 | 0.532 | 0.241 | Analgesic | 0.241 0.19 CID_3007 | CID_3007 | |
| 0.015 | 0.592 | 0.123 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.123 0.113 CID_3007 | CID_3007 | |
| 0.013 | 0.615 | 0.123 | Protein kinase (CK1) gamma 3 inhibitor | 0.123 0.122 CID_3007 | CID_3007 | |
| 0.019 | 0.647 | 0.142 | Interleukin 6 antagonist | 0.142 0.101 CID_3007 | CID_3007 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |